Dental Care Clinics in Madison, GA Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Orthodontic Care Of Georgia Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1690 Eatonton Rd, Madison, GA 30650 Phone: 706-342-7272 Fax: 706-342-7747 |
Michael C. Montgomery D.m.d.,p.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1040 Barclay Dr, Madison, GA 30650 Phone: 706-342-1242 |
Madisondentalgroupllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1040 Barclay Dr, Madison, GA 30650 Phone: 706-342-1242 |
Scherer & Paulk, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2151 Eatonton Rd Ste D, Madison, GA 30650 Phone: 706-751-1910 |
News Archive
Antigenics' Oncophage cancer vaccine trial starts enrolling patients
Antigenics Inc. (NASDAQ:AGEN) today announced that the Brain Tumor Research Center at the University of California, San Francisco, has begun enrolling patients into a Phase 2 clinical trial of Oncophage (vitespen) in combination with the standard of care - radiation therapy plus Temodar (temozolomide) - for newly diagnosed glioma patients.
Failed state exchanges set sights too high, say experts
Common themes characterize several failed state exchanges, including trying to do too much the first year and having tangled lines of authority, reports CQ HealthBeat.
Scientists report efficient way to transform A and B blood into neutral type
Every day, thousands of people need donated blood. But only blood without A- or B-type antigens, such as type O, can be given to all of those in need, and it's usually in short supply. Now scientists are making strides toward fixing the situation. In ACS' Journal of the American Chemical Society, they report an efficient way to transform A and B blood into a neutral type that can be given to any patient.
BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
AIDS vaccine still long way off
Researchers are optimistic about a potential HIV/AIDS vaccine, even though none of the vaccines in development is likely to completely protect people from HIV transmission, participants at the XVI International AIDS Conference in Toronto said at a news conference Tuesday, Reuters reports.
› Verified 1 days ago